Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia von Ojamies, P N, Kontro, M, Edgren, H, Ellonen, P, Lagström, S, Almusa, H, Miettinen, T, Eldfors, S, Tamborero, D, Wennerberg, K, Heckman, C, Porkka, K, Wolf, M, Kallioniemi, O

Volltext

Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML von Malani, D, Murumägi, A, Yadav, B, Kontro, M, Eldfors, S, Kumar, A, Karjalainen, R, Majumder, M M, Ojamies, P, Pemovska, T, Wennerberg, K, Heckman, C, Porkka, K, Wolf, M, Aittokallio, T, Kallioniemi, O

Volltext

Precision systems medicine in urological Tumors – Molecular profiling and functional testing von Saeed, K., Ojamies, P., Pellinen, T., Rahkama, V., Eldfors, S., Paavolainen, L., Turkki, R., Horvath, P., Lundin, J., Nisen, H., af Hällström, T.M., Rannikko, A., Mirtti, T., Kallioniemi, O., Östling, P.

Volltext

Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient‐derived cancer cells von Saeed, Khalid, Ojamies, Poojitha, Pellinen, Teijo, Eldfors, Samuli, Turkki, Riku, Lundin, Johan, Järvinen, Petrus, Nisen, Harry, Taari, Kimmo, af Hällström, Taija M., Rannikko, Antti, Mirtti, Tuomas, Kallioniemi, Olli, Östling, Päivi

Volltext

Establishment and high-throughput drug testing of multiple patient-derived cells from each renal cancer; intratumor heterogeneity of drug response and implications for precision me... von Saeed, K, Ojamies, P, Pellinen, T, Eldfors, S, Turkki, R, Lundin, J, Nisen, H, Jarvinen, P, Taari, K, af Hallstrom, T, Rannikko, A, Mirtti, T, Kallioniemi, O, Ostling, P

Volltext